Post-Transplant Cyclophosphamide (PTCY) Improves Outcomes Among Allogeneichematopoietic Cell Transplantation (HSCT) Recipients with High Comorbidity Score Compared to Standardgraft-Versus-Host Disease (GVHD) Prophylaxis

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Tanya Lutfeali Lalani, Carla Rozier, AaravB.S. KokaneStudent, Stephanie Gregory, Asad Bashey, Lizamarie Bachier‐Rodriguez, Joseph E. Maakaron, H. Kent Holland, Scott R. Solomon, Melhem Solh
DOI: 10.1016/j.jtct.2025.12.663
Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Renal Transplantation Outcomes and Treatments Transplantation: Methods and Outcomes

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S449–S449
Publication date
1 February 2026
Language
EN